BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Trials

ACROMEC's associated Life Science Incubator launches Co-working Labspace

ACROMEC Limited a specialist engineering services provider, announced that subsidiary ACROMEC Engineers Pte Ltd (ACROMEC Engineers) through joint-venture a...

September 24, 2021 | News

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

September 23, 2021 | News

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety D...

September 21, 2021 | News

Jemincare declared Ph I trial of its anti-SARS-CoV-2 neutralizing antibody

The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phas...

September 14, 2021 | News

Novavax Launches Ph 1 & 2 ,Clinical Trial of Combined COVID-19 and Seasonal Influenza Vaccine

First participants enrolled in Phase 1 clinical trial of NanoFlu combination vaccineTM/NVX–CoV2373 with Matrix-M adjuvantTM Novavax, Inc. (Nasdaq:&n...

September 11, 2021 | News

Illumina Partners with Merck to advance cancer diagnostics and precision medicine.

Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop an...

September 08, 2021 | News

Odyssey Group Approved to Start Human Trial to Treat Concussion

The Company’s Clinical Trial Protocol was approved by the Alfred Ethics Committee and allows for the immediate start of the human trial. “We a...

September 08, 2021 | News

Stem Cells for Everyone: I Peace expands its clinical-grade

I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-winning technology of ...

September 08, 2021 | News

NuProbe Enables Rapid Ultrasensitive Mutation Detection

he method, termed oncogene concatenated enriched amplicon nanopore sequencing (OCEANS), enables rapid, accurate, and affordable detection of somatic mutati...

September 07, 2021 | News

CSL Behring Underscores its Commitment to Respiratory Patients with Strong Focus on Research

Focusing on what we have learnt about the impact of global Covid-19 pandemic on pulmonary disease research, it will also explore the latest updates in the ...

September 06, 2021 | News

Pfizer Starts PhIII Clinical Trial in Adults for Its Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease), a...

September 02, 2021 | News

Cough monitoring smartphone app incorporated into year-long respiratory research trial

Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, rece...

August 31, 2021 | News

Senhwa's Silmitasertib Receives US FDA Fast Track Designation

Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...

August 19, 2021 | News

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood...

August 12, 2021 | News

Stay Connected